The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for V Guagnano


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors.EBI
Novartis Institutes For Biomedical Research
Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors.EBI
Novartis Institutes For Biomedical Research
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.EBI
Novartis Institutes For Biomedical Research
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.EBI
Novartis Institute For Biomedical Research
Entry into a new class of protein kinase inhibitors by pseudo ring design.EBI
Novartis Institutes For Biomedical Research
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor.EBI
Novartis Institutes For Biomedical Research
Process route of compound of formula (IV), crystal form and preparation method thereforBDB
Shandong Danhong Pharmaceutical Co.
Pyrazole carboxamides as Janus kinase inhibitorsBDB
Merck Sharp & Dohme
Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.BDB
Nanjing University
Pyridine compounds and the users thereofBDB
Purdue Pharma
Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereofBDB
TBA
Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitorsBDB
Merck Sharp & Dohme
A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.BDB
Mirpur University of Science and Technology (Must)
Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.BDB
UniversitÉ
Muscarinic cholinergic binding in rat brain.BDB
TBA
Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.BDB
University of Arizona
Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.BDB
University of Pittsburgh